Appointment of CFO
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kabra Drugs Ltd announced a change at the Chief Financial Officer position on 08th October 2025. Mr. Bangalore Venkatakrishnappa Ananth Kumar resigned as CFO and Key Managerial Personnel, effective the same day. Mr. T. Pavanasam, a Commerce Graduate with over 15 years of experience in finance, taxation, and allied laws across various industries, has been appointed as the new CFO and KMP, also effective 08th October 2025. The change was approved by the Board on the recommendation of the Nomination and Remuneration Committee and the Audit Committee.
A routine CFO transition with both outgoing and incoming CFOs taking effect on the same day, suggesting a planned handover. Investors should watch for any further disclosures about the reasons behind the change, though no immediate material impact on operations or shareholder value is indicated.